Research suggests mental health disorders can spread socially. It’s hard to prove, but “exposures” may drive awareness.

Patients with rheumatologic diseases are far more likely to experience mood disorders, including anxiety and depression.

Increasing prevalence of anxiety and depression, coupled with innovation in pharmaceutical treatments and growing demand for mental health solutions, fuels growth in the anxiety disorders and ...

Placebos Reduce Stress, Anxiety, Depression -- Even When People Know They Are Placebos Aug. 23, 2024 — A study found that nondeceptive placebos, or placebos given with people fully knowing they ...

Anxiety and depression are more common among people with Crohn’s disease, and they can worsen symptoms. Here’s why and ways ...

Miindfulness-based stress reduction may be as effective as escitalopram (Lexapro — an SSRI commonly used to treat depression ...

For many people, being displaced by a disaster has long-term consequences that often aren’t obvious or considered in disaster aid decisions.

Except, this time, the wedding wasn't in the near or distant future — it had already happened. Lauren Cook, PsyD, is a ...

The Boston-based biotech will use the new fundraise to develop its pipeline of drug candidates for conditions such as major ...

A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.

The Boston-based startup is developing what executives hope will be more effective treatments for depression, anxiety, and ...

Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt ...